Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg Tablets

Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg combines an angiotensin-receptor blocker and a thiazide diuretic for high blood pressure. The complementary actions on blood vessels and salt balance help when combination therapy is needed.
Take in the morning, with or without food, to reduce night-time urination. Rise slowly if dizzy. Kidney function, sodium and potassium are monitored because the net electrolyte effect cannot be predicted from the two ingredients alone.
Olmesartan blocks angiotensin II at AT1 receptors. Hydrochlorothiazide increases sodium and water loss through the kidneys, reducing circulating volume and blood pressure.
Dizziness, increased urination, dehydration and changes in sodium or potassium may occur. Severe weakness, palpitations, fainting or markedly reduced urination needs assessment.
Pregnancy, dehydration and significant kidney dysfunction are important risks. Hydrochlorothiazide can raise uric acid and worsen gout. Lithium and NSAIDs can interact. Persistent diarrhoea with weight loss warrants assessment of olmesartan-related enteropathy.
Combines complementary mechanisms for sustained blood-pressure reduction when one agent is insufficient.
The hydrochlorothiazide component can increase urination; earlier use usually reduces sleep disruption.
Yes. Olmesartan can raise potassium while hydrochlorothiazide can lower it; monitoring shows the net effect.
The thiazide can increase uric acid and trigger a flare in susceptible people.
NSAIDs can reduce the antihypertensive effect and increase kidney risk, especially during dehydration.
It often means the treatment is effective. Ongoing measurements guide changes rather than symptoms alone.
Hydrochlorothiazide: a thiazide diuretic. ARB: an angiotensin-receptor blocker. Hyperuricaemia: raised uric acid. Hyponatraemia: low blood sodium; AR: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg أقراص; FR: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg comprimés; PT: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg comprimidos; ES: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg comprimidos; RU: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg таблетки; ID: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg tablet; VI: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg viên nén; MS: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg tablet; TL: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg tableta; ZH-SG: Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg Tablets